IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOBambusa Therapeutics, Inc.

About

Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of immunological and inflammatory disorders.

The company develops BBT001 for Type 2 inflammatory dermatological conditions, including atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis. It also develops BBT002, a long-acting bispecific antibody for respiratory and other Type 2 inflammatory diseases.

Bambusa Therapeutics, Inc. Overview

Ticker, listing venue and issuer profile

TickerBBTX
ExchangeNASDAQ
Statusfiled
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CIK Code2044950
CUSIP--
ISINUS0589371030

Offer & Key Dates

Pricing terms and IPO milestones

Price Range$15.00 - $17.00
Offer Price$16.00
Listing Price$14.88
Current Price$14.99
Shares Offered10.56M
Shares Outstanding50.94M
Offer Size$168.89M
Market Cap$763.63M
Filing DateOct 09, 2026
Priced Date--
Listed DateOct 30, 2026

Live Market Snapshot

Real-time price and trading activity

$14.99+0.74% All time

USD · NASDAQ:NASDAQ:BBTX

Open$14.88
High$15.66
Low$13.60
Volume2,200,121
52W High--
52W Low--
Market Cap$745.93M
Enterprise Value--

Valuation & Multiples

Key valuation ratios and metrics

P / E--
P / Book--
P / Sales--
EV / EBITDA--
EPS--
Revenue / Share (TTM)--
Revenue$0.00
Net Income-$41.09M

Financial Health

Balance sheet strength and liquidity

Total Debt--
Total Assets--
Cash$50.64M
Free Cash Flow--
Current Ratio9.76
Quick Ratio--
Debt / Equity--
CapEx--

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

FormFiling DateDocument
424B4Oct 30, 2026Prospectus
S-8Oct 30, 2026Securities to be offered to employees in employee benefit plans
EFFECTOct 29, 2026Notice of Effectiveness
S-1MEFOct 29, 2026Registration adding securities to prior Form S-1 registration
CERTOct 29, 2026Certification by an exchange approving securities for listing
8-A12BOct 27, 2026Registration of securities
S-1/AOct 26, 2026[Amend] General form for registration of securities under the Securities Act of 1933
S-1Oct 9, 2026General form for registration of securities under the Securities Act of 1933
DRS/ASep 15, 2026[Amend] [Cover] Draft Registration Statement
DRSAug 3, 2026[Cover] Draft Registration Statement

Company Info

Contact and headquarters details

Websitehttps://www.bambusatx.com
HeadquartersUnited States
Founded2024
Employees30
Phone(617) 848-6188
Address22 Boston Wharf Road, Floor 7Boston, Massachusetts 02210United States

Leadership

Key executives and officers

SX

Shanshan Xu, M.D., Ph.D., M.B.A.

Co-Founder, Chief Executive Officer, President, and Chairperson

JI

Jonathan I. Lieber, M.B.A.

Chief Financial Officer

TH

Thang Ho, Ph.D.

Co-Founder and Chief Development Officer

CM

Crystal MacKay

Chief Operating Officer

DD

Derek DiRocco, Ph.D.

Director

CF

Christian Foerster, M.Sc.

Director

HJ

Helmut Jeggle, M.B.A.

Co-Founder and Director

HL

Howard Liang, Ph.D., M.B.A.

Lead Independent Director

Bambusa Therapeutics, Inc. IPO - FAQs

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BAMBUSA THERAPEUTICS INC stocks are traded under the ticker BBTX.

Quick Facts

Exchange
NASDAQ
Ticker
BBTX
Deal Type
IPO
Offer Size
$168.89M
Market Cap
$763.63M
Shares Offered
10.56M

Company Info

Website
https://www.bambusatx.com
Headquarters
United States
Founded
2024
Employees
30
Phone
(617) 848-6188
Address
22 Boston Wharf Road, Floor 7Boston, Massachusetts 02210United States
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc.

BBTXNASDAQ
filed

Issue Size

$168.89M

Price Range

$15.00 - $17.00

Shares

50.94M o/s · 10.56M offered

Listing Price

$14.88

Probable listing

Oct 30, 2026

Sector

Healthcare

Filed

Oct 09, 2026